Showing results (2961-2970 of 4,140) with videos related to
Sort By:
Pageof 414
Human Gene Therapy|February 4, 1998
Lentiviral vectors for gene therapy of cystic fibrosisM J Goldman, P S Lee, J S Yang, et al.Human Gene Therapy|February 11, 1998
Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cellsH Namba, M Tagawa, Y Iwadate, et al.Human Gene Therapy|February 11, 1998
Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectorsM Hildinger, B Fehse, S Hegewisch-Becker, et al.Human Gene Therapy|February 11, 1998
Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genesD Jung, E Jaeger, S Cayeux, et al.Human Gene Therapy|February 7, 1998
Characterization of an internal ribosomal entry segment within the 5' leader of avian reticuloendotheliosis virus type A RNA and development of novel MLV-REV-based retroviral vectorsM López-Lastra, C Gabus, J L DarlixHuman Gene Therapy|February 24, 1998
High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocolM Movassagh, C Desmyter, C Baillou, et al.Human Gene Therapy|February 24, 1998
A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosisM R Knowles, P G Noone, K Hohneker, et al.Human Gene Therapy|June 2, 1998
Dose-dependent doxycycline-mediated adrenocorticotropic hormone secretion from encapsulated Tet-on proopiomelanocortin Neuro2A cells in the subarachnoid spaceY Saitoh, Y Eguchi, Y Hagihara, et al.Human Gene Therapy|June 2, 1998
Enhanced green fluorescent protein as an efficient reporter gene for retroviral transduction of human multipotent lymphoid precursorsA R Ramiro, V G De Yébenes, C Trigueros, et al.Human Gene Therapy|June 13, 1998
Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: comparison of two different Epstein-Barr virus-based vectorsS Kenney, J Q Ge, E M Westphal, et al.Pageof 414